Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Fourmarier

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
World Journal of Urology|June 25, 2026
Bladder drainage using the coreflow prostatic stent after REZUM therapyThibaut Long-Depaquit, Frederica Sordelli, Anne Laure Charvet, et al.
The French Journal of Urology|February 21, 2025
Comparative analysis of functional and economic outcomes of prostatic urethral lift and water vapor thermal therapy for male LUTS: A French perspectiveThibaut Long Depaquit, Roxane Reus, Alessandro Uleri, et al.
World Journal of Urology|January 13, 2025
Water vapor thermal therapy for treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia (≥ 80 g)Christopher Agüero, Thibaut Long Depaquit, Alessandro Uleri, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)]Alexandre De la Taille, Marc Fourmarier, Francois Desgrandchamps, et al.
BJU International|October 19, 2010
Randomized, crossover study evaluating patient preference and the impact on quality of life of urisheaths vs absorbent products in incontinent menEmmanuel Chartier-Kastler, Philippe Ballanger, Jacques Petit, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2006
[Role of prostatic stents and transurethral microwave thermotherapy in the treatment of voiding disorders related to benign prostatic hyperplasia (CTMH-AFU forum 2005)], Christian Saussine, Marian Devonec, et al.
World Journal of Urology|May 20, 2006
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxinAbdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps, et al.
World Journal of Urology|September 22, 2021
Intravesical instillation of high molecular weight sodium hyaluronate in radiation-induced cystitis: a prospective pilot studyMichael Baboudjian, Marc Fourmarier, Christophe Clement, et al.
BJU International|May 11, 2026
Comparative 30-day life cycle assessment of bladder drainage strategiesArthur Peyrottes, Thibaut Long-Depaquit, Marc Fourmarier, et al.
BJU International|January 22, 2009
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a reviewAurélien Descazeaud, Gregoire Robert, Abdel Rahmene Azzousi, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
World Journal of Urology|June 25, 2026
Bladder drainage using the coreflow prostatic stent after REZUM therapyThibaut Long-Depaquit, Frederica Sordelli, Anne Laure Charvet, et al.
The French Journal of Urology|February 21, 2025
Comparative analysis of functional and economic outcomes of prostatic urethral lift and water vapor thermal therapy for male LUTS: A French perspectiveThibaut Long Depaquit, Roxane Reus, Alessandro Uleri, et al.
World Journal of Urology|January 13, 2025
Water vapor thermal therapy for treatment of lower urinary tract symptoms due to large benign prostatic hyperplasia (≥ 80 g)Christopher Agüero, Thibaut Long Depaquit, Alessandro Uleri, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|July 20, 2007
[Value of antidiuretic, anticholinergic, and anti-inflammatory drugs and botulinum toxin for the treatment of voiding disorders related to BPH (CTMH-AFU forum 2005)]Alexandre De la Taille, Marc Fourmarier, Francois Desgrandchamps, et al.
BJU International|October 19, 2010
Randomized, crossover study evaluating patient preference and the impact on quality of life of urisheaths vs absorbent products in incontinent menEmmanuel Chartier-Kastler, Philippe Ballanger, Jacques Petit, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|December 21, 2006
[Role of prostatic stents and transurethral microwave thermotherapy in the treatment of voiding disorders related to benign prostatic hyperplasia (CTMH-AFU forum 2005)], Christian Saussine, Marian Devonec, et al.
World Journal of Urology|May 20, 2006
Other therapies for BPH patients: desmopressin, anti-cholinergic, anti-inflammatory drugs, and botulinum toxinAbdel-Rahmène Azzouzi, Marc Fourmarier, Francois Desgrandchamps, et al.
World Journal of Urology|September 22, 2021
Intravesical instillation of high molecular weight sodium hyaluronate in radiation-induced cystitis: a prospective pilot studyMichael Baboudjian, Marc Fourmarier, Christophe Clement, et al.
BJU International|May 11, 2026
Comparative 30-day life cycle assessment of bladder drainage strategiesArthur Peyrottes, Thibaut Long-Depaquit, Marc Fourmarier, et al.
BJU International|January 22, 2009
Laser treatment of benign prostatic hyperplasia in patients on oral anticoagulant therapy: a reviewAurélien Descazeaud, Gregoire Robert, Abdel Rahmene Azzousi, et al.
Pageof 5